2014 Europe Tumor Marker Testing Market : Next 5 Years Business Opportunities in Cancer Diagnostics Industry adds report 2014 Strategies for the European Tumor Marker Testing Market to its store. This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.

Complete report is available at

This comprehensive five-country report identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Purchase Report Directly @

Table of Contents


Worldwide Market and Technology Overview

France, Germany, Italy, Spain, U.K.

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

Potential Market Entry Barriers and Risks

Competitive Profiles
Abbott, AdnaGen, Agilent Technologies, Applied Gene Technologies, Arca/Nuvelo, Beckman Coulter/Danaher, Becton Dickinson, Biomedical Diagnostics, bioMerieux, Bio-Rad, CellSearch ,Cepheid, Correlogic Systems/Vermillion, Decode, Diadexus, Diagnocure, Diasorin, Eiken Chemical, Epigenomics, Enterix, EnzBiochem, Exact Sciences, Fujirebio/Innogenetics, Guided Therapeutics, Hologic/Gen-Probe, Kreatech, Kyowa Medex, Life Technologies, Mackay Life Sciences, Myriad Genetics, Nanogen Elitech, OncoLabOrtho-Clinical Diagnostics, Panacea Pharmaceuticals, Polartechnics, Polymedco, PreMD, Qiagen/Ipsogen, Quest Diagnostics, Radient Pharmaceuticals, Roche. Scienion, Sequenom, Siemens Healthcare, Takara Bio, Targeted Diagnostics & Therapeutics, Tosoh, Veridex, WakPure Chemicals, Wallac/PE, Zila

Get Discount @

XV. Appendixes:

Appendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications

Appendix II: Assumed Currency Exchange Rates

List of Tables

Tumor Marker Classification

Executive Summary Table: France, Total Cancer Diagnostic Test Volume and Sales Forecast By Market Segment

Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment

Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment

Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment

Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment

Request Sample for this Report 2014 Strategies for the European Tumor Marker Testing Market at before making a purchase decision.

About Us: is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on  and we would be happy to help you find the business intelligence that you need. Not limited to the Cancer offers research studies on agriculture, consumer goods, environment, advanced materials, public sector, food and beverages, energy and power, medical devices, healthcare, automotive, manufacturing & construction, semiconductor and electronics, IT & telecommunication, pharmaceuticals, retail, water, banking and financial services , advanced materials and much more.